FCMI
Foresite Capital Management IV Portfolio holdings
AUM
$124M
This Quarter Return
+70.74%
1 Year Return
-24.36%
3 Year Return
+1.86%
5 Year Return
+16.17%
10 Year Return
–
AUM
$205M
AUM Growth
+$205M
(+153%)
Cap. Flow
+$74.5M
Cap. Flow
% of AUM
36.28%
Top 10 Holdings %
Top 10 Hldgs %
99.39%
Holding
18
New
7
Increased
2
Reduced
2
Closed
6
Top Buys
| 1 |
Keros Therapeutics
KROS
|
$53.6M |
| 2 |
Kura Oncology
KURA
|
$19.8M |
| 3 |
Vaxcyte
PCVX
|
$19.6M |
| 4 |
Generation Bio
GBIO
|
$18M |
| 5 |
CBAY
Cymabay Therapeutics
CBAY
|
$9.92M |
Top Sells
| 1 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
$17.5M |
| 2 |
Cytokinetics
CYTK
|
$13.4M |
| 3 |
Insmed
INSM
|
$10.9M |
| 4 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$5.32M |
| 5 |
AERI
Aerie Pharmaceuticals, Inc.
AERI
|
$3.07M |
Sector Composition
| 1 | Healthcare | 99.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Keros Therapeutics
KROS
$618M
| $53.6M | 26.09% | +1,428,071 | New | +$53.6M |
|
|
2
Cytokinetics
CYTK
$4.23B
| $37.9M | 18.45% | 1,607,292 -570,000 | -26% | -$13.4M |
|
|
3
Kura Oncology
KURA
$686M
| $21.3M | 10.39% | 1,307,982 +1,214,982 | +1,306% | +$19.8M |
|
4
Fulcrum Therapeutics
FULC
$351M
| $20.7M | 10.1% | 1,133,948 +135,293 | +14% | +$2.47M |
|
|
5
Vaxcyte
PCVX
$4B
| $19.6M | 9.56% | +620,821 | New | +$19.6M |
|
|
6
Generation Bio
GBIO
$40.4M
| $18M | 8.78% | +857,942 | New | +$18M |
|
|
MYOK
7
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $12.2M | 5.95% | 126,492 -180,908 | -59% | -$17.5M |
|
|
CBAY
8
DELISTED
Cymabay Therapeutics
CBAY
| $9.93M | 4.83% | +2,843,893 | New | +$9.92M |
|
9
Voyager Therapeutics
VYGR
$186M
| $6.52M | 3.18% | 516,751 | – | – |
|
10
Oric Pharmaceuticals
ORIC
$994M
| $4.22M | 2.05% | +125,000 | New | +$4.22M |
|
|
DRNA
11
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $635K | 0.31% | +25,000 | New | +$635K |
|
12
Travere Therapeutics
TVTX
$1.56B
| $612K | 0.3% | +30,000 | New | +$612K |
|
|
BLUE
13
DELISTED
bluebird bio
BLUE
| – | – | -50,000 | Closed | -$2.3M |
|
|
14
Insmed
INSM
$28.8B
| – | – | -678,322 | Closed | -$10.9M |
|
15
Kiniksa Pharmaceuticals
KNSA
$2.48B
| – | – | -65,000 | Closed | -$1.01M |
|
16
uniQure
QURE
$896M
| – | – | -19,082 | Closed | -$905K |
|
|
AERI
17
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| – | – | -227,717 | Closed | -$3.07M |
|
|
BHVN
18
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| – | – | -156,355 | Closed | -$5.32M |
|